Guangdi Wang
Molecular Biology · 2015
A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 26 citations into it
Whom Guangdi Wang trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Ricky W. Johnstone (in Molecular Biology)
- PA Marks (in Molecular Biology)
Papers from Guangdi Wang's perspective
Ordered by how strongly the researchers Guangdi Wang trusts endorse each paper. Same corpus, a different order for every researcher.
- Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases. (Structure)
- Anticancer activities of histone deacetylase inhibitors (Nature reviews. Drug discovery)
- Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes (Nature Medicine)
- Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. (Biochemical and Biophysical Research Communications - BBRC)
- Histone Deacetylase Inhibitors for Cancer Therapy (Epigenetics)
- Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). (Blood)
- Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor. (Proceedings of the National Academy of Sciences of the United States of America)
- Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. (Journal of Molecular Biology)
- Histone deacetylase inhibitors. (European journal of medicinal chemistry)
- Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer. (Journal of Clinical Oncology)
Their papers
- Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents (2015) — 631 citations